Money for the research projects comes from the state’s medical marijuana patient fees, not Colorado’s new taxes on recreational pot, according to the report.
Specifically, the Colorado studies will test marijuana’s potential to treat epilepsy, brain tumors, irritable bowel syndrome, pain relief and Parkinson’s disease. Studies will also focus on the impact of medical marijuana on veterans with post-traumatic stress disorder.
Several of the studies are still awaiting federal approval from the Food and Drug Administration, the Drug Enforcement Administration, and either the National Institutes of Health or HHS, according to the report.
In addition to federal clearance, three of the eight research projects also need access to marijuana, for which there is only one legal source in the country, the Marijuana Research Project at the University of Mississippi.
More articles on population health:
Cancer survivors to account for 5% of the US population in 2022
5 strategies that combine mHealth and population health
Enhanced patient engagement: The key to population health management?
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
